Assessment of the need for palliative care in patients with heart failure depending on body composition
https://doi.org/10.15829/1560-4071-2025-6126
EDN: SZAESC
Abstract
Aim. To assess the need for palliative care (PC) in patients with heart failure (HF) depending on body composition.
Material and methods. The study involved 298 people (115 men and 183 women, mean age — 61 [53;69] years), who were divided into 5 groups depending on body composition — obesity and sarcopenia. Left ventricular ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and galectin-3 markers were determined. Kaplan-Meier analysis was performed to assess survival, while Cox regression — the influence of factors.
Results. The maximum values of the time of need for PC are characteristic of patients without body composition disorders, and the minimum ones are for patients with sarcopenic obesity. According to Cox regression, a significant increase in hazard ratio for PC indications occurrence was revealed as 22,9 times (p<0,001) with an increase in muscle mass index to body mass index ratio (MMI/BMI) by 1; 1,99 times (p<0,001) with an increase in functional class by 1; 1-1,02 times (p=0,002) with an increase in the galectin level by 1 ng/mL; 0,96 times (p<0,001) with a decrease in the Barthel index by 1; and 3,71 times (p<0,001) in the presence of sarcopenia.
Conclusion. The body composition of patients with HF affects the functional activity of the patient, and therefore the need for PC in patients.
About the Authors
V. I. Shevtsova
Burdenko Voronezh State Medical University
Russian Federation
Competing Interests:
Russian Federation
Voronezh
Competing Interests:
нет
A. A. Pashkova
Burdenko Voronezh State Medical University
Competing Interests:
Voronezh
Competing Interests:
нет
O. N. Krasnorutskaya
Burdenko Voronezh State Medical University
Competing Interests:
Voronezh
Competing Interests:
нет
References
1. Rashid MA, Novikov GA, Vajsman MA, et al. Palliative care for chronic heart failure: relevance, tasks and problems. Palliative medicine and rehabilitation. 2022;3:14-24. (In Russ.)
2. Novikov GA, Vvedenskaya ES, Zelenova OV, et al. The results of the first epidemiological study in Russia of the needs of cancer patients in palliative care and evaluation of the effectiveness and safety of diagnostic methods for pathological symptoms. Palliative medicine and rehabilitation. 2018;4:5-10. (In Russ.)
3. Boytsov SA, Drapkina OM, Shlyakhto EV, et al. Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later. Cardiovascular Therapy and Prevention. 2021;20(5):3007. (In Russ.) doi: 10.15829/1728-8800-2021-3007.
4. Grigorieva II, Raskina TA, Letaeva MV, et al. Sarcopenia: pathogenesis and diagnosis. Fundamental and Clinical Medicine. 2019;4(4):105-16. (in Russ.) doi: 10.23946/2500-0764-2019-4-4-105-116.
5. Mikaelyan AA, Varaeva YuR, Liskova YuV, et al. Sarcopenia and chronic heart failure. Part 1. Lechebnoe delo. 2023;2:51-6. (In Russ.) doi: 10.24412/2071-5315-2023-12879. EDN LRAULA.
6. Formiga F, Moreno-Gónzalez R, Corsonello A, et al.; SCOPE Investigators. Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease. Gerontology. 2024;70(5):507-16. doi: 10.1159/000536465.
7. Kılıç R, Güzel T, Aktan A, et al. Prevalence of sarcopenia in heart failure with mildly reduced ejection fraction and its impact on clinical outcomes. Acta Cardiol. 2024:1-9. doi: 10.1080/00015385.2024.2410604.
8. Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. (In Russ.) doi: 10.18087/cardio.2021.4.n1628.
9. Larina VN, Chukaeva II, Larin VG. Current Trends and Possibilities of Providing Medical Palliative Care in Chronic Heart Failure. Kardiologiia. 2019;59(1):84-92. (In Russ.) doi: 10.18087/cardio.2019.1.10219.
10. Serezhina EK, Obrezan AG. Features of phenotyping patients with heart failure with preserved ejection fraction. Russian Journal of Cardiology. 2023;28(3S):5348. (In Russ.) doi: 10.15829/1560-4071-2023-5348. EDN ONOGLD.
11. Rubanenko OA, Skripnik IV, Matyukhina KV, et al. Short Registry of Terminal Forms of Chronic Heart Failure in the Samara Region. Kardiologiia. 2024;64(3):46-54. (In Russ.)
12. Shiga T, Suzuki A, Haruta S. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475-86. doi: 10.1002/ehf2.12418.
13. Shevcova VI, Pashkova AA, Kolpacheva MG, et al. The level of the biomarker galectin-3 in patients with chronic heart failure. Nauchno-medicinskij vestnik Central'nogo Chernozem'ya. 2024;96:75-81. (In Russ.)
14. Drapkina OM, Skripnikova IA, Yaralieva EK, et al. Body composition in patients with heart failure. Cardiovascular Therapy and Prevention. 2022;21(12):3451. (In Russ.) doi: 10.15829/1728-8800-2022-3451.
15. Gulyaev NI, Adamov AA, Ahmetshin IM. The effect of sarcopenia on the course and prognosis in patients with chronic heart failure. Mediko-farmacevticheskij zhurnal "Pul's". 2023;25(2):124-33. (In Russ.)
Supplementary files
- Body composition disorders affect the need for palliative care in patients with heart failure; in patients without sarcopenia, it is 4 times less than in patients with sarcopenia.
- Muscle mass index to body mass index ratio, functional class, galectin level, Barthel index, and sarcopenia were included in the proportional hazards model for indications for palliative care.
Review
For citations:
Shevtsova V.I., Pashkova A.A., Krasnorutskaya O.N. Assessment of the need for palliative care in patients with heart failure depending on body composition. Russian Journal of Cardiology. 2025;30(3):6126. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6126. EDN: SZAESC
Views:
95
Email this article 